-
Uncategorized5 months agoSTAT+: Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients
Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer cells in patients with B-cell lymphoma three times better than standard care — achieving...
-
Uncategorized5 months ago
Ideaya’s uveal melanoma drug exceeds success benchmark in late-stage trial
Ideaya’s late-stage data for a rare eye cancer drug has passed the company’s benchmark for success, bolstering expectations for a planned accelerated filing in the US....
-
Uncategorized5 months ago
Rethinking dermatology trial design for late-stage success
A smarter approach to dermatology trials—built for durability and real-world impact. Read More
-
Uncategorized5 months agoSTAT+: Hospitals roll out chatbots, looking to reclaim their role in patients’ health conversations
Every day, more than 40 million people ask ChatGPT about health care, according to OpenAI. They’re asking questions about diet, exercise, insurance — and in some...
-
Uncategorized5 months ago
Seaport and Hemab file for IPOs, with Kailera expected to price soon
The spring IPO cohort is starting to take shape. On Friday night, neuroscience drug developer Seaport Therapeutics and blood clotting disorder biotech Hemab Therapeutics both filed...
-
Uncategorized5 months ago
Solar-driven biosynthesis of chemicals from phosphite-rich wastewater and carbon dioxide
Solar-driven biosynthesis of chemicals from phosphite-rich wastewater and carbon dioxide
-
Uncategorized5 months ago
Hydrophobic tuning with non-canonical amino acids in a copper metalloenzyme
Post Content
-
Uncategorized5 months ago
Design of the biosensor-dependent coupling system stabilizes the high-synthesis phenotype of cell factory
Post Content
-
Uncategorized5 months ago
GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
-
Uncategorized5 months agoOpinion: What STAT readers think about nutrition education in med school
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and...
Generic Drugs
China plans to transform $3M biotech sector into $522B powerhouse by 2030
FDA approves imlunestrant in combination with abemaciclib for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
